B
BioTissue is the leader in innovative technologies using products derived from human amniotic and umbilical cord tissues. Since its inception in 1997, the Company has pioneered the clinical application of human placental tissues – more than 680,000 patients have been treated with BioTissue products and the Company’s groundbreaking scientific and clinical achievements have been documented in more than 380 peer-reviewed publications.
Investor insights
Funding rounds participated in
$82M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Funding rounds raised
Total raised
$82M
from 1 investors over 1 rounds
B
BioTissue raised $82M on July 26, 2019
Investors: Essex Woodlands Healthcare Partners